AAPL302.77-2.14 (-0.70%) ▼|ABBV249.31-0.79 (-0.31%) ▼|ABT109.67-0.05 (-0.05%) ▼|ACN176.67-3.16 (-1.75%) ▼|ADBE256.71-7.00 (-2.65%) ▼|AMAT548.64+23.03 (+4.38%) ▲|AMD490.92+16.60 (+3.50%) ▲|AMGN415.00+0.70 (+0.17%) ▲|AMT171.13+1.58 (+0.93%) ▲|AMZN269.65-2.62 (-0.96%) ▼|AVGO422.36+6.28 (+1.51%) ▲|AXP340.62-0.20 (-0.06%) ▼|BA230.18-3.06 (-1.31%) ▼|BAC64.44+0.44 (+0.69%) ▲|BKNG209.84-3.03 (-1.42%) ▼|BLK1,151.98+3.14 (+0.27%) ▲|BMY63.95+0.34 (+0.53%) ▲|BNY163.13+2.81 (+1.75%) ▲|BRK-B509.18-7.20 (-1.39%) ▼|C138.42+2.65 (+1.95%) ▲|CAT863.94+20.57 (+2.44%) ▲|CL92.39+0.08 (+0.09%) ▲|CMCSA25.31-0.34 (-1.33%) ▼|COF219.88+0.73 (+0.33%) ▲|COP125.68-0.25 (-0.19%) ▼|COST945.96+1.64 (+0.17%) ▲|CRM193.31-4.16 (-2.11%) ▼|CSCO124.08+3.65 (+3.03%) ▲|CVS93.54+0.04 (+0.04%) ▲|CVX196.57-0.10 (-0.05%) ▼|DE613.18-4.78 (-0.77%) ▼|DHR203.97-3.48 (-1.68%) ▼|DIS103.06-0.47 (-0.45%) ▼|DUK123.22+0.03 (+0.02%) ▲|EMR163.45-0.93 (-0.57%) ▼|FDX321.16-1.27 (-0.39%) ▼|GD391.27-0.62 (-0.16%) ▼|GE365.20-2.86 (-0.78%) ▼|GEV1,043.00+31.12 (+3.08%) ▲|GILD136.48+0.71 (+0.52%) ▲|GM87.20-2.15 (-2.41%) ▼|GOOG341.76-1.24 (-0.36%) ▼|GOOGL342.97-0.83 (-0.24%) ▼|GS1,049.70+15.29 (+1.48%) ▲|HD344.16-10.33 (-2.91%) ▼|HON230.21+0.09 (+0.04%) ▲|IBM233.17-5.25 (-2.20%) ▼|INTC101.66+3.95 (+4.04%) ▲|INTU330.80-5.64 (-1.68%) ▼|ISRG397.71-3.52 (-0.88%) ▼|JNJ260.28+0.48 (+0.18%) ▲|JPM365.44+3.40 (+0.94%) ▲|KO86.57+0.09 (+0.10%) ▲|LIN484.43-6.10 (-1.24%) ▼|LLY1,216.11+1.09 (+0.09%) ▲|LMT598.14+0.37 (+0.06%) ▲|LOW215.27-5.98 (-2.70%) ▼|LRCX327.41+16.00 (+5.14%) ▲|MA557.64-3.80 (-0.68%) ▼|MCD272.85-1.30 (-0.47%) ▼|MDLZ61.51-0.27 (-0.44%) ▼|MDT89.30-1.39 (-1.53%) ▼|META585.70-13.43 (-2.24%) ▼|MMM181.90-1.23 (-0.67%) ▼|MO64.93-0.10 (-0.15%) ▼|MRK132.46+2.04 (+1.56%) ▲|MS220.32+5.25 (+2.44%) ▲|MSFT494.73-9.08 (-1.80%) ▼|MU926.36+57.84 (+6.66%) ▲|NEE85.99+0.25 (+0.29%) ▲|NFLX73.81-0.99 (-1.32%) ▼|NKE40.60-0.73 (-1.75%) ▼|NOW123.36-4.18 (-3.28%) ▼|NVDA224.73+7.23 (+3.32%) ▲|ORCL149.28+3.80 (+2.61%) ▲|PEP137.33-1.09 (-0.78%) ▼|PFE26.32-0.31 (-1.15%) ▼|PG144.23-0.98 (-0.67%) ▼|PLTR168.71-6.24 (-3.56%) ▼|PM185.79-0.43 (-0.23%) ▼|QCOM162.65-0.04 (-0.02%) ▼|RTX220.42-3.45 (-1.54%) ▼|SBUX106.81+0.15 (+0.14%) ▲|SCHW108.18+0.48 (+0.45%) ▲|SO92.11+0.19 (+0.21%) ▲|SPG219.48-0.05 (-0.02%) ▼|T24.42-0.09 (-0.35%) ▼|TMO597.01-7.99 (-1.32%) ▼|TMUS177.68-0.91 (-0.51%) ▼|TSLA325.04-7.78 (-2.34%) ▼|TXN280.60-0.64 (-0.23%) ▼|UBER76.13-2.41 (-3.07%) ▼|UNH403.86+1.67 (+0.41%) ▲|UNP292.34-0.54 (-0.18%) ▼|UPS103.19-1.24 (-1.19%) ▼|USB64.62+0.33 (+0.51%) ▲|V359.84-2.99 (-0.82%) ▼|VZ47.02-0.26 (-0.54%) ▼|WFC88.31+0.86 (+0.98%) ▲|WMT114.77+1.51 (+1.33%) ▲|XOM158.76-1.04 (-0.65%) ▼|AAPL302.77-2.14 (-0.70%) ▼|ABBV249.31-0.79 (-0.31%) ▼|ABT109.67-0.05 (-0.05%) ▼|ACN176.67-3.16 (-1.75%) ▼|ADBE256.71-7.00 (-2.65%) ▼|AMAT548.64+23.03 (+4.38%) ▲|AMD490.92+16.60 (+3.50%) ▲|AMGN415.00+0.70 (+0.17%) ▲|AMT171.13+1.58 (+0.93%) ▲|AMZN269.65-2.62 (-0.96%) ▼|AVGO422.36+6.28 (+1.51%) ▲|AXP340.62-0.20 (-0.06%) ▼|BA230.18-3.06 (-1.31%) ▼|BAC64.44+0.44 (+0.69%) ▲|BKNG209.84-3.03 (-1.42%) ▼|BLK1,151.98+3.14 (+0.27%) ▲|BMY63.95+0.34 (+0.53%) ▲|BNY163.13+2.81 (+1.75%) ▲|BRK-B509.18-7.20 (-1.39%) ▼|C138.42+2.65 (+1.95%) ▲|CAT863.94+20.57 (+2.44%) ▲|CL92.39+0.08 (+0.09%) ▲|CMCSA25.31-0.34 (-1.33%) ▼|COF219.88+0.73 (+0.33%) ▲|COP125.68-0.25 (-0.19%) ▼|COST945.96+1.64 (+0.17%) ▲|CRM193.31-4.16 (-2.11%) ▼|CSCO124.08+3.65 (+3.03%) ▲|CVS93.54+0.04 (+0.04%) ▲|CVX196.57-0.10 (-0.05%) ▼|DE613.18-4.78 (-0.77%) ▼|DHR203.97-3.48 (-1.68%) ▼|DIS103.06-0.47 (-0.45%) ▼|DUK123.22+0.03 (+0.02%) ▲|EMR163.45-0.93 (-0.57%) ▼|FDX321.16-1.27 (-0.39%) ▼|GD391.27-0.62 (-0.16%) ▼|GE365.20-2.86 (-0.78%) ▼|GEV1,043.00+31.12 (+3.08%) ▲|GILD136.48+0.71 (+0.52%) ▲|GM87.20-2.15 (-2.41%) ▼|GOOG341.76-1.24 (-0.36%) ▼|GOOGL342.97-0.83 (-0.24%) ▼|GS1,049.70+15.29 (+1.48%) ▲|HD344.16-10.33 (-2.91%) ▼|HON230.21+0.09 (+0.04%) ▲|IBM233.17-5.25 (-2.20%) ▼|INTC101.66+3.95 (+4.04%) ▲|INTU330.80-5.64 (-1.68%) ▼|ISRG397.71-3.52 (-0.88%) ▼|JNJ260.28+0.48 (+0.18%) ▲|JPM365.44+3.40 (+0.94%) ▲|KO86.57+0.09 (+0.10%) ▲|LIN484.43-6.10 (-1.24%) ▼|LLY1,216.11+1.09 (+0.09%) ▲|LMT598.14+0.37 (+0.06%) ▲|LOW215.27-5.98 (-2.70%) ▼|LRCX327.41+16.00 (+5.14%) ▲|MA557.64-3.80 (-0.68%) ▼|MCD272.85-1.30 (-0.47%) ▼|MDLZ61.51-0.27 (-0.44%) ▼|MDT89.30-1.39 (-1.53%) ▼|META585.70-13.43 (-2.24%) ▼|MMM181.90-1.23 (-0.67%) ▼|MO64.93-0.10 (-0.15%) ▼|MRK132.46+2.04 (+1.56%) ▲|MS220.32+5.25 (+2.44%) ▲|MSFT494.73-9.08 (-1.80%) ▼|MU926.36+57.84 (+6.66%) ▲|NEE85.99+0.25 (+0.29%) ▲|NFLX73.81-0.99 (-1.32%) ▼|NKE40.60-0.73 (-1.75%) ▼|NOW123.36-4.18 (-3.28%) ▼|NVDA224.73+7.23 (+3.32%) ▲|ORCL149.28+3.80 (+2.61%) ▲|PEP137.33-1.09 (-0.78%) ▼|PFE26.32-0.31 (-1.15%) ▼|PG144.23-0.98 (-0.67%) ▼|PLTR168.71-6.24 (-3.56%) ▼|PM185.79-0.43 (-0.23%) ▼|QCOM162.65-0.04 (-0.02%) ▼|RTX220.42-3.45 (-1.54%) ▼|SBUX106.81+0.15 (+0.14%) ▲|SCHW108.18+0.48 (+0.45%) ▲|SO92.11+0.19 (+0.21%) ▲|SPG219.48-0.05 (-0.02%) ▼|T24.42-0.09 (-0.35%) ▼|TMO597.01-7.99 (-1.32%) ▼|TMUS177.68-0.91 (-0.51%) ▼|TSLA325.04-7.78 (-2.34%) ▼|TXN280.60-0.64 (-0.23%) ▼|UBER76.13-2.41 (-3.07%) ▼|UNH403.86+1.67 (+0.41%) ▲|UNP292.34-0.54 (-0.18%) ▼|UPS103.19-1.24 (-1.19%) ▼|USB64.62+0.33 (+0.51%) ▲|V359.84-2.99 (-0.82%) ▼|VZ47.02-0.26 (-0.54%) ▼|WFC88.31+0.86 (+0.98%) ▲|WMT114.77+1.51 (+1.33%) ▲|XOM158.76-1.04 (-0.65%) ▼|
27.2 C
New York
Wednesday, August 12, 2026

Tag: Nasdaq:CBIO

newssourceFORcompanyinformationcontent1releasesmarket

Crescent Biopharma Announces Grants of Inducement Awards

WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 65,100 shares of the Company’s ordinary shares to three non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on June 25, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).

Crescent Biopharma to Present at June Investor Conferences

WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNasdaq:CBIO

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers